Dipeptidyl dipeptidase-4 (DPP-4) inhibitors (DPP-4 i) have been broadly applied in clinical aspects for controlling blood glucose levels in type 2 diabetic patients (T2DP). Here, DPP4 is linked to type 2 diabetes mellitus.